stella
beta
Clinical Utility of a Genomic Predictor Test on the Management of Cardiorenal Complications of Type 2 Diabetes — Stella
Home
/
Diabetes Mellitus, Type 2
/
Clinical Utility of a Genomic Predictor Test on the Management of Cardiorenal Complications of Type 2 Diabetes
View on ClinicalTrials.gov
Recruiting
Back to Diabetes Mellitus, Type 2 trials
Clinical Utility of a Genomic Predictor Test on the Management of Cardiorenal Complications of Type 2 Diabetes
Not a traditional drug trial — this study doesn't follow the standard phase structure.
Trial locations
(2 sites)
Canada
CHUM, Montreal, Quebec
ELNA Medical, Montreal, Quebec